JP2001527567A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001527567A5 JP2001527567A5 JP1998549992A JP54999298A JP2001527567A5 JP 2001527567 A5 JP2001527567 A5 JP 2001527567A5 JP 1998549992 A JP1998549992 A JP 1998549992A JP 54999298 A JP54999298 A JP 54999298A JP 2001527567 A5 JP2001527567 A5 JP 2001527567A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9710521.7A GB9710521D0 (en) | 1997-05-22 | 1997-05-22 | Process |
| GB9710521.7 | 1997-05-22 | ||
| PCT/EP1998/003167 WO1998052539A1 (en) | 1997-05-22 | 1998-05-20 | Process for making flurbiprofen lozenges |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001527567A JP2001527567A (ja) | 2001-12-25 |
| JP2001527567A5 true JP2001527567A5 (https=) | 2005-12-08 |
Family
ID=10812840
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54999298A Ceased JP2001527567A (ja) | 1997-05-22 | 1998-05-20 | フルルビプロフェン舐剤を製造する方法 |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6194003B1 (https=) |
| EP (1) | EP0983059B1 (https=) |
| JP (1) | JP2001527567A (https=) |
| KR (1) | KR20010012739A (https=) |
| CN (1) | CN1154480C (https=) |
| AR (1) | AR015812A1 (https=) |
| AT (1) | ATE245021T1 (https=) |
| AU (1) | AU725760B2 (https=) |
| BG (1) | BG103881A (https=) |
| BR (1) | BR9809651A (https=) |
| CA (1) | CA2290830C (https=) |
| CZ (1) | CZ290816B6 (https=) |
| DE (1) | DE69816440T2 (https=) |
| DK (1) | DK0983059T3 (https=) |
| ES (1) | ES2202871T3 (https=) |
| GB (1) | GB9710521D0 (https=) |
| HU (1) | HU224954B1 (https=) |
| ID (1) | ID22949A (https=) |
| IL (1) | IL132999A0 (https=) |
| IN (1) | IN187837B (https=) |
| MY (1) | MY118410A (https=) |
| NO (1) | NO995681L (https=) |
| NZ (1) | NZ500664A (https=) |
| PL (1) | PL190947B1 (https=) |
| PT (1) | PT983059E (https=) |
| RU (1) | RU2203046C2 (https=) |
| SK (1) | SK283701B6 (https=) |
| TR (1) | TR199902725T2 (https=) |
| UA (1) | UA53714C2 (https=) |
| WO (1) | WO1998052539A1 (https=) |
| ZA (1) | ZA984260B (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1235558T3 (da) | 1999-12-09 | 2006-10-09 | Reckitt Benckiser Healthcare | Sammenpresset tabletsammensætning, der omfatter et NSAID |
| AU5702201A (en) * | 2000-04-13 | 2001-10-30 | Mayo Foundation | Abeta<sub>42</sub> lowering agents |
| JP4886107B2 (ja) * | 2000-10-13 | 2012-02-29 | サンスター株式会社 | 歯周病予防用口腔内溶解錠 |
| WO2004071431A2 (en) * | 2003-02-05 | 2004-08-26 | Myriad Genetics, Inc. | Method and composition for treating neurodegenerative disorders |
| KR20060040676A (ko) * | 2003-07-11 | 2006-05-10 | 미리어드 제네틱스, 인크. | 알츠하이머병을 치료하기 위한 약제학적 방법, 투약 방법및 제형 |
| FR2865648B1 (fr) * | 2004-02-03 | 2006-06-30 | Philippe Perovitch | Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede |
| WO2006001877A2 (en) * | 2004-04-13 | 2006-01-05 | Myriad Genetics, Inc. | Combination treatment for neurodegenerative disorders comprising r-flurbiprofen |
| AU2005241023A1 (en) * | 2004-04-29 | 2005-11-17 | Keystone Retaining Wall Systems, Inc. | Veneers for walls, retaining walls and the like |
| WO2006020852A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
| WO2006020850A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
| WO2006020853A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
| AU2006211023B2 (en) | 2005-02-03 | 2012-05-24 | Takeda Nycomed As | Fast wet-massing method for the preparation of calcium-containing compositions |
| GB2423710A (en) | 2005-03-01 | 2006-09-06 | Boots Healthcare Int Ltd | Lozenge production process |
| KR20080039876A (ko) * | 2005-07-22 | 2008-05-07 | 미리어드 제네틱스, 인크. | 높은 약물 충진 제형 및 투여형 |
| CA2620219A1 (en) * | 2005-11-02 | 2007-05-18 | Teikoku Pharma Usa, Inc. | Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same |
| EP2046119A2 (en) * | 2006-07-07 | 2009-04-15 | Myriad Genetics, Inc. | Treatment of psychiatric disorders |
| WO2009014960A1 (en) * | 2007-07-23 | 2009-01-29 | Teikoku Pharma Usa, Inc. | Organoleptically acceptable indole serotonin receptor agonist oral dosage formulations and methods of using the same |
| AU2009284011B2 (en) * | 2008-08-22 | 2013-12-12 | Reckitt Benckiser Healthcare (Uk) Limited | Sore throat compositions |
| IT1397132B1 (it) | 2009-12-01 | 2013-01-04 | Alfa Wassermann Spa | Composizioni comprendenti antiinfiammatori non steroidei. |
| IT1406107B1 (it) * | 2010-12-13 | 2014-02-14 | Alfa Wassermann Spa | Composizioni solide comprendenti antiinfiammatori non steroidei, processi per la loro preparazione e loro uso. |
| SMT202100228T1 (it) | 2011-04-29 | 2021-05-07 | Moberg Pharma Ab | Composizioni farmaceutiche comprendenti un anestetico locale come bupivacaina per somministrazione locale alla bocca o alla gola |
| EP2609911A1 (en) * | 2011-12-29 | 2013-07-03 | Sanovel Ilac Sanayi ve Ticaret A.S. | A novel process for preparing orally disintegrating flurbiprofen formulations |
| FR2997856B1 (fr) * | 2012-11-14 | 2015-04-24 | Pf Medicament | Pastille medicamenteuse a base d'ibuprofene sodique dihydrate |
| US20180228832A1 (en) * | 2015-08-18 | 2018-08-16 | Pharma Seeds Create, Llc | Stomatological composition containing nsaid or heparin compound |
| WO2020013781A2 (en) * | 2018-03-27 | 2020-01-16 | Pisak Mehmet Nevzat | Synergistic effect of flurbiprofen and a gastro protective agent for the treatment of pain and inflammation |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
| US4666716A (en) * | 1984-09-04 | 1987-05-19 | Richardson-Vicks Inc. | Antidiarrheal compositions and use thereof |
| RU2026670C1 (ru) * | 1988-10-05 | 1995-01-20 | Дзе Апджон Компани | Способ получения тонкодисперсного твердого фармацевтического вещества |
| IT1243342B (it) * | 1990-07-13 | 1994-06-10 | Farcon Ag | Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria |
| IT1244698B (it) * | 1991-02-01 | 1994-08-08 | Gentili Ist Spa | Acidi aril-o arilalchil-acil ammino-alchil-idrossidifosfonici, procedimento per la loro preparazione e loro uso in terapia osteo-articolare e dei tessuti connettori in generale |
| US5302394A (en) * | 1992-07-14 | 1994-04-12 | Mcneil-Ppc, Inc. | Dextromethorphan continuous lozenge manufacturing process |
| US5458879A (en) * | 1994-03-03 | 1995-10-17 | The Procter & Gamble Company | Oral vehicle compositions |
| TW442287B (en) * | 1995-06-13 | 2001-06-23 | American Home Produits Corp | Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac) |
| US5614207A (en) * | 1995-06-30 | 1997-03-25 | Mcneil-Ppc, Inc. | Dry mouth lozenge |
| GB9523833D0 (en) * | 1995-11-22 | 1996-01-24 | Boots Co Plc | Medical treatment |
-
1997
- 1997-05-22 GB GBGB9710521.7A patent/GB9710521D0/en active Pending
-
1998
- 1998-05-20 ES ES98929394T patent/ES2202871T3/es not_active Expired - Lifetime
- 1998-05-20 TR TR1999/02725T patent/TR199902725T2/xx unknown
- 1998-05-20 BR BR9809651-6A patent/BR9809651A/pt not_active IP Right Cessation
- 1998-05-20 SK SK1588-99A patent/SK283701B6/sk not_active IP Right Cessation
- 1998-05-20 WO PCT/EP1998/003167 patent/WO1998052539A1/en not_active Ceased
- 1998-05-20 UA UA99127003A patent/UA53714C2/uk unknown
- 1998-05-20 KR KR1019997010700A patent/KR20010012739A/ko not_active Ceased
- 1998-05-20 IL IL13299998A patent/IL132999A0/xx not_active IP Right Cessation
- 1998-05-20 PL PL336624A patent/PL190947B1/pl unknown
- 1998-05-20 EP EP98929394A patent/EP0983059B1/en not_active Expired - Lifetime
- 1998-05-20 CZ CZ19994120A patent/CZ290816B6/cs not_active IP Right Cessation
- 1998-05-20 CA CA002290830A patent/CA2290830C/en not_active Expired - Fee Related
- 1998-05-20 AT AT98929394T patent/ATE245021T1/de not_active IP Right Cessation
- 1998-05-20 NZ NZ500664A patent/NZ500664A/xx not_active IP Right Cessation
- 1998-05-20 RU RU99126868/14A patent/RU2203046C2/ru not_active IP Right Cessation
- 1998-05-20 HU HU0002121A patent/HU224954B1/hu not_active IP Right Cessation
- 1998-05-20 ZA ZA984260A patent/ZA984260B/xx unknown
- 1998-05-20 ID IDW991324A patent/ID22949A/id unknown
- 1998-05-20 PT PT98929394T patent/PT983059E/pt unknown
- 1998-05-20 DE DE69816440T patent/DE69816440T2/de not_active Expired - Lifetime
- 1998-05-20 US US09/403,771 patent/US6194003B1/en not_active Expired - Lifetime
- 1998-05-20 AU AU79165/98A patent/AU725760B2/en not_active Ceased
- 1998-05-20 CN CNB988051230A patent/CN1154480C/zh not_active Expired - Fee Related
- 1998-05-20 DK DK98929394T patent/DK0983059T3/da active
- 1998-05-20 JP JP54999298A patent/JP2001527567A/ja not_active Ceased
- 1998-05-21 AR ARP980102364A patent/AR015812A1/es not_active Application Discontinuation
- 1998-05-21 IN IN1090MA1998 patent/IN187837B/en unknown
- 1998-05-22 MY MYPI98002295A patent/MY118410A/en unknown
-
1999
- 1999-11-15 BG BG103881A patent/BG103881A/xx unknown
- 1999-11-19 NO NO995681A patent/NO995681L/no not_active Application Discontinuation